Dark

SPRO
Spero Therapeutics, Inc. Common Stock
stock NASDAQ

Market Open

Jun 3, 2025 12:45:14 PM EDT

2.65USD-3.285%(-0.09)1,344,550

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 3, 2025 9:28:30 AM EDT

2.75USD+0.365%(+0.01)144,867

After-hours

Jun 2, 2025 4:54:30 PM EDT

2.71USD-1.095%(-0.03)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

148.44M

CEO

Ankit Mahadevia

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

OMER XLV

SPRO Stats

Avg. Vol. 10 Day

22,230,143

Avg. Vol. 30 Day

7,476,579

Employees

Market Cap

148,442,752

Shares Out.

55,910,641

On/Off Exchange

52%/48%

6 Month Beta

0.34

1 Year Beta

0.37

2 Year Beta

0.51

3 Year Beta

0.61

52 Week Low

0.51

52 Week High

2.95

SMA50

0.83

SMA200

1.03

1 Week

+289.30%

1 Month

+310.36%

3 Month

+244.76%

6 Month

+128.88%

1 Year

+85.66%

2 Year

+45.88%

5 Year

-78.45%

Profile

spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.

SPRO Stock Summary

Spero Therapeutics, Inc. Common Stock (NASDAQ:SPRO) stock price today is $2.65, and today's volume is 1,344,550. SPRO is down -3.285% today. The 30 day average volume is 7,476,579. SPRO market cap is 148.44M with 55,910,641 shares outstanding.